Compare ZVRA & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZVRA | MAGN |
|---|---|---|
| Founded | 2006 | 1864 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 502.7M | 536.8M |
| IPO Year | 2015 | N/A |
| Metric | ZVRA | MAGN |
|---|---|---|
| Price | $8.92 | $13.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $21.71 | $18.00 |
| AVG Volume (30 Days) | ★ 1.0M | 495.6K |
| Earning Date | 03-10-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | $84,388,000.00 | ★ $3,204,000,000.00 |
| Revenue This Year | $333.64 | $5.74 |
| Revenue Next Year | $43.58 | $2.51 |
| P/E Ratio | $16.79 | ★ N/A |
| Revenue Growth | ★ 244.60 | 46.50 |
| 52 Week Low | $6.19 | $7.82 |
| 52 Week High | $13.16 | $23.19 |
| Indicator | ZVRA | MAGN |
|---|---|---|
| Relative Strength Index (RSI) | 54.06 | 43.60 |
| Support Level | $8.75 | $13.22 |
| Resistance Level | $9.60 | $14.26 |
| Average True Range (ATR) | 0.46 | 0.54 |
| MACD | 0.04 | -0.19 |
| Stochastic Oscillator | 58.55 | 20.32 |
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.